On a weekly basis I write a regular article for The Motley Fool — an online investment newsletter—discussing how scientific and technological breakthroughs from just the past week might impact a variety of different industries and companies. Although it is written primarily with the individual investor in mind, the column is also a useful read for executives and managers who are interested in jumping the curve. This week’s article reviews how progress in the fields of neurorobotic surgery, nanotechnology and “printable” organs will transform the health care sector. The full article can be read here.
